RxE2
PrivateLast Round
Seed
Oct 20, 2022
Total Funding Raised
$4M
Company Overview
RxE2 operates in Healthcare & Life Sciences and is based in Fargo, North Dakota. Its latest recorded funding round was a Seed round in October 2022.
RxE2 is a healthcare technology company that provides a platform to integrate community pharmacists into clinical trials to enhance patient recruitment, adherence, and data quality.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxE2 Comparables
Compare RxE2 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curebase | 79% | |
| eMed | 77% | |
| ObvioHealth | 77% |
For institutional investors. Book with your work email.
RxE2 Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RxE2 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| O'Leary Ventures | Seed |
| Badlands Capital | Seed |
| MATTER | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Launched the "Pharm-to-Trial" model utilizing local pharmacies.
- Oct 10, 2025
Will be attending the NCPA 2025 event.
For institutional investors. Book with your work email.
RxE2 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RxE2's valuation, stock price, and market status.
Is RxE2 a public or private company?
RxE2 is a private company.
What is the current stock price of RxE2?
RxE2 is a private company, so its shares have no public market price. Caplight tracks RxE2's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RxE2 worth (valuation)?
Valuation information for RxE2 is not publicly available.
Can I buy RxE2 stock?
RxE2 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RxE2's last funding round?
RxE2's most recent funding round was Seed on October 20, 2022.
Who are the main investors in RxE2?
Key investors in RxE2 include O'Leary Ventures.
Will RxE2 IPO soon?
No public IPO plans have been announced for RxE2.
How can I track RxE2 secondary market activity?
Caplight tracks bids, offers, and trades in RxE2's shares on secondary markets.